
Prolacta is the pioneer in human milk-based nutritional products for critically ill and premature infants in the neonatal intensive care unit (NICU). Prolacta believes that there is no adequate replacement for human breast milk and, as such, we believe infant nutritional products should be human milk-based. As a scientifically driven company committed to improving premature infant nutrition, we are using human milk to change the standard of care in the NICU. Read more »
PremieLact™ is ready-to-feed, pasteurized human milk for trophic feeds. When mother’s milk is unavailable, PremieLact may be used as the initial feeding of a 100% human milk diet. PremieLact provides approximately 0.7 kcal and 0.012 grams of protein per mL and contains no added minerals.
The CMSA conference & expo will be in Phoenix, AZ. Prolacta Bioscience will be exhibiting at booth #712.
Randomized Clinical Trial
"A Randomized Controlled Trial of Human versus Bovine-Based Human Milk Fortifiers in Extremely Preterm Infants"
